National Cancer Institute

05/28/2026

There is encouraging news for people diagnosed with multiple myeloma.

The FDA recently approved two new treatment combinations for patients receiving their first treatment for multiple myeloma. In clinical trials, these treatments helped patients go longer without their cancer getting worse and led to stronger treatment responses.

Researchers also saw more patients reach “MRD negativity,” meaning highly sensitive tests could not find remaining myeloma cells after treatment.

These advances are helping improve care and creating more options for patients and their healthcare teams. https://go.nih.gov/LyOkPq3

05/27/2026

New research published in Nature is offering hope for children and young adults with aggressive brain cancers known as diffuse midline gliomas.

In an early clinical trial, an experimental CAR T-cell therapy helped shrink tumors in several patients, with some also experiencing improved neurological function and longer survival.

Researchers say the findings could help advance the future of immunotherapy for solid tumors.

Read more: https://go.nih.gov/2kOdxc4

05/21/2026

An NIH-funded study showed that cancer mutations in immune cells of the brain, called microglia, help drive Alzheimer's Disease.

According to Dr. Christopher Walsh, co-lead investigator of the study, “We find that to some extent, Alzheimer’s disease is a little like cancer—driven by the same mutations that drive blood cancers like lymphoma and leukemia. This is helpful because we have a lot of drugs to fight cancer and some of them might be useful therapeutically for Alzheimer’s disease.” https://go.nih.gov/ESmVxwq

05/21/2026

NCI-supported researchers have discovered how pancreatic tumors evade KRAS-targeted therapies—and how we might block that escape route. Targeting a key protein could resensitize resistant cancers and extend treatment response. https://www.nature.com/articles/d42473-025-00434-x

05/20/2026

This Oncology Nursing Month, we recognize research nurses as essential drivers of cancer innovation.

They are often the first point of contact for patients—guiding them into clinical trials, advancing discovery, and ensuring care remains human at every step.

At NCI, breakthroughs depend on this partnership between science and compassion—because progress only matters if it reaches people.

05/19/2026

What if a simple wearable device could help improve life for people with brain tumors?

This Brain Tumor Awareness Month, we’re highlighting research showing how smart wearables can track sleep, activity, and heart rate—helping scientists better understand symptoms and support care.

By combining technology with patient input, researchers are finding new ways to turn everyday data into meaningful insights. https://www.cancer.gov/rare-brain-spine-tumor/blog/2024/smart-wearables-show-promise-for-tracking-sleep-patterns-in-brain-tumor-patients

05/18/2026

This Brain Tumor Awareness Month, we’re highlighting NCI-CONNECT—a program dedicated to improving understanding and care for rare brain and spine tumors.

These cancers are uncommon but complex, and patients often face challenges finding expertise and treatment options. NCI-CONNECT brings together patients, providers, researchers, and advocates to build a stronger network—sharing knowledge, advancing research, and opening doors to clinical trials.

Together, we are working to turn rare into understood—and understanding into better care. Learn more: https://www.cancer.gov/rare-brain-spine-tumor/

05/11/2026

CT scans are a critical tool in modern medicine—but interpreting them takes time, and there aren’t enough radiologists to meet growing demand.

New NIH-funded research highlights how artificial intelligence may help. Scientists developed a model that can analyze 3D CT scans to support diagnosis—and even identify patterns that may predict future disease risk.

This work illustrates the growing impact of emerging technologies in healthcare. By combining human expertise with advanced tools, we have the opportunity to improve efficiency, uncover new insights, and ultimately provide better care for patients. Read more:

An AI-powered tool can interpret 3D images from CT scans and diagnose certain disorders.

05/08/2026

NCI-supported researchers are working to advance our understanding of how to prevent, detect early, and treat . Learn more: https://www.cancer.gov/types/ovarian/research

05/07/2026

NEWS: NIH-supported scientists discovered that hormones associated with male development may play a key role in limiting the growth of brain tumors in men.

In an analysis of data from more than 1,300 men with glioblastoma, researchers found that supplemental testosterone significantly improved survival. The findings were consistent with preclinical experiments showing the loss of testosterone drove tumor growth.

Read the full story ➡️ http://bit.ly/49xAGLf